These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 10716680)

  • 21. Genes modulated by histone acetylation as new effectors of butyrate activity.
    Della Ragione F; Criniti V; Della Pietra V; Borriello A; Oliva A; Indaco S; Yamamoto T; Zappia V
    FEBS Lett; 2001 Jun; 499(3):199-204. PubMed ID: 11423116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of histone deacetylation by butyrate induces morphological changes in Y79 retinoblastoma cells.
    Karasawa Y; Okisaka S
    Jpn J Ophthalmol; 2004; 48(6):542-51. PubMed ID: 15592778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of complement component (C3 and factor B) biosynthesis by a histone deacetylase inhibitor in human intestinal epithelial cells.
    Andoh A; Fujiyama Y; Shimada M; Bamba T
    Int J Mol Med; 2000 Jul; 6(1):51-4. PubMed ID: 10851266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase.
    Kim YB; Lee KH; Sugita K; Yoshida M; Horinouchi S
    Oncogene; 1999 Apr; 18(15):2461-70. PubMed ID: 10229197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Butyrate switches the pattern of chemokine secretion by intestinal epithelial cells through histone acetylation.
    Fusunyan RD; Quinn JJ; Fujimoto M; MacDermott RP; Sanderson IR
    Mol Med; 1999 Sep; 5(9):631-40. PubMed ID: 10551904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture.
    Niki T; Rombouts K; De Bleser P; De Smet K; Rogiers V; Schuppan D; Yoshida M; Gabbiani G; Geerts A
    Hepatology; 1999 Mar; 29(3):858-67. PubMed ID: 10051490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Keratin 23 (K23), a novel acidic keratin, is highly induced by histone deacetylase inhibitors during differentiation of pancreatic cancer cells.
    Zhang JS; Wang L; Huang H; Nelson M; Smith DI
    Genes Chromosomes Cancer; 2001 Feb; 30(2):123-35. PubMed ID: 11135429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors.
    Ishihara K; Takahashi A; Kaneko M; Sugeno H; Hirasawa N; Hong J; Zee O; Ohuchi K
    Life Sci; 2007 Mar; 80(13):1213-20. PubMed ID: 17258775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of telomerase activity in human liver cancer cells by a histone deacetylase inhibitor.
    Nakamura M; Saito H; Ebinuma H; Wakabayashi K; Saito Y; Takagi T; Nakamoto N; Ishii H
    J Cell Physiol; 2001 Jun; 187(3):392-401. PubMed ID: 11319763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone deacetylase inhibitors promote osteoblast maturation.
    Schroeder TM; Westendorf JJ
    J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils.
    Ishihara K; Hong J; Zee O; Ohuchi K
    Br J Pharmacol; 2004 Jul; 142(6):1020-30. PubMed ID: 15210580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
    Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
    Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity.
    Munshi A; Kurland JF; Nishikawa T; Tanaka T; Hobbs ML; Tucker SL; Ismail S; Stevens C; Meyn RE
    Clin Cancer Res; 2005 Jul; 11(13):4912-22. PubMed ID: 16000590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetylation of histones associated with the p21WAF1/CIP1 gene by butyrate is not sufficient for p21WAF1/CIP1 gene transcription in human colorectal adenocarcinoma cells.
    Kobayashi H; Tan EM; Fleming SE
    Int J Cancer; 2004 Mar; 109(2):207-13. PubMed ID: 14750171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Butyrate Stimulates Histone H3 Acetylation, 8-Isoprostane Production, RANKL Expression, and Regulated Osteoprotegerin Expression/Secretion in MG-63 Osteoblastic Cells.
    Chang MC; Chen YJ; Lian YC; Chang BE; Huang CC; Huang WL; Pan YH; Jeng JH
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30562925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors.
    Countryman JK; Gradoville L; Miller G
    J Virol; 2008 May; 82(10):4706-19. PubMed ID: 18337569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma.
    Heider U; Kaiser M; Sterz J; Zavrski I; Jakob C; Fleissner C; Eucker J; Possinger K; Sezer O
    Eur J Haematol; 2006 Jan; 76(1):42-50. PubMed ID: 16343270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells.
    Mathew OP; Ranganna K; Yatsu FM
    Biomed Pharmacother; 2010 Dec; 64(10):733-40. PubMed ID: 20970954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells.
    Archer SY; Meng S; Shei A; Hodin RA
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6791-6. PubMed ID: 9618491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells.
    Takai N; Desmond JC; Kumagai T; Gui D; Said JW; Whittaker S; Miyakawa I; Koeffler HP
    Clin Cancer Res; 2004 Feb; 10(3):1141-9. PubMed ID: 14871994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.